Osteoarthritis
📧 Sign up to get email alerts when something new happens for Osteoarthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-02-14Clinical Trial Update: Study of Safety, Tolerability, Preliminary Efficacy of Intra-articular LNA043 Injections in Patients With Articular Cartilage Lesions and Knee Osteoarthritis. [Phase 2]
Phase 2 study assessing safety, tolerability, and preliminary efficacy of intra-articular LNA043 injections for articular cartilage lesions …
-
CLINICAL_TRIALS withdrawal · 2024-02-06Clinical Trial Update: Investigating RELEARN Neurofeedback as Treatment for Chronic Musculoskeletal Pain [Phase 2, Phase 3]
A Phase 2/Phase 3 trial investigating RELEARN Neurofeedback for chronic musculoskeletal pain has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2024-02-06Clinical Trial Update: Does Electrocautery Increase Postoperative Pain in Primary Total Knee Arthroplasty [Phase 3]
A Phase 3 clinical trial is examining whether electrocautery increases postoperative pain after primary total knee arthroplasty in patients …
-
CLINICAL_TRIALS research · 2024-01-29Clinical Trial Update: Preventing Posttraumatic Osteoarthritis With Physical Activity Promotion [NA]
Clinical trial completion reporting on promoting physical activity to prevent posttraumatic osteoarthritis after ACL injuries.
-
CLINICAL_TRIALS trial_result · 2024-01-05Clinical Trial Update: Cam Type FAI is a Cause of Hip Pain in the Young Adult and a Precursor to OA [Phase 2]
Phase 2 clinical trial investigating cam-type femoroacetabular impingement as a cause of hip pain in young adults and its role as a precurso…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-01-03Clinical Trial Update: Efficacy of Allogeneic UCMSCs for Treating Large Defects Knee Injury [Phase 2]
Phase 2 trial update on using allogeneic UCMSCs to treat knee osteoarthritis shows completed study.
-
FDA approval · 2023-12-28FDA Approved: MELOXICAM — Supplemental Application (AiPing Pharmaceutical, Inc)
FDA approved AiPing Pharmaceutical, Inc.'s supplemental application for MELOXICAM (meloxicam).
-
CLINICAL_TRIALS trial_result · 2023-12-01Clinical Trial Update: Effect of Diacerein vs Celecoxib on Symptoms and Structural Changes in Symptomatic Knee Osteoarthritis [Phase 3]
A Phase 3 trial comparing diacerein to celecoxib in symptomatic knee osteoarthritis assessing symptoms and structural changes; trial complet…
-
FDA approval · 2023-11-29FDA Approved: VOLTAREN ARTHRITIS PAIN — Supplemental Application (Haleon US Holdings LLC)
The FDA approved a supplemental application for Voltaren Arthritis Pain (diclofenac sodium) submitted by Haleon US Holdings LLC. This action…
-
CLINICAL_TRIALS trial_result · 2023-11-24Clinical Trial Update: Study to Assess the Efficacy and Safety of Meloxicam vs. Diclofenac SR in Patients With Osteoarthritis of the Knee [Phase 4]
A Phase 4 trial compared meloxicam to diclofenac SR for efficacy and safety in knee osteoarthritis and has completed.
-
CLINICAL_TRIALS trial_result · 2023-11-02Clinical Trial Update: Chronic Pain Master Protocol (CPMP): A Study of LY3556050 in Participants With Osteoarthritis [Phase 2]
Phase 2 study updates for LY3556050 in osteoarthritis as part of a chronic pain master protocol; results posted after completion.
-
FDA approval · 2023-10-20FDA Approved: COXANTO — Original Application (SOLA Pharmaceuticals, LLC)
The FDA approved COXANTO (oxaprozin) from SOLA Pharmaceuticals in its original application, enabling its use for pain and inflammation assoc…
-
CLINICAL_TRIALS trial_result · 2023-10-19Clinical Trial Update: Saline-Controlled Study of nSTRIDE APS for Knee Osteoarthritis [NA]
A completed saline-controlled study of nSTRIDE APS for knee osteoarthritis with posted results.
-
CLINICAL_TRIALS trial_result · 2023-10-13Clinical Trial Update: Zimmer POLAR - Total Knee Arthroplasty (TKA) [NA]
Clinical trial update for Zimmer POLAR total knee arthroplasty (TKA) with completed status and results posted.
-
FDA approval · 2023-10-11FDA Approved: NAPROXEN AND ESOMEPRAZOLE MAGNESIUM — Original Application (ScieGen Pharmaceuticals, Inc)
FDA approved Naproxen and Esomeprazole Magnesium (ScieGen Pharmaceuticals) under Original Application. The combination is indicated for reli…
-
CLINICAL_TRIALS trial_result · 2023-10-10Clinical Trial Update: Ascension® Post- Approval Study; PyroCarbon Metacarpophalangeal Total Joint Prosthesis [NA]
Clinical trial update for Ascension post-approval study reporting termination with results posted.
-
CLINICAL_TRIALS trial_result · 2023-09-22Clinical Trial Update: Effect of Zoledronic Acid in Primary Knee Osteoarthritis [Phase 4]
A Phase 4 clinical trial update assessing the effect of zoledronic acid in primary knee osteoarthritis is ongoing with an unknown status.
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: A Trial of HRF2105 Patch in Relieving Pain of Osteoarthritis [Phase 2]
Phase 2 trial update for HRF2105 patch intended to relieve pain in osteoarthritis.
-
CLINICAL_TRIALS trial_result · 2023-09-18Clinical Trial Update: Effects of Perioperative Intravenous Dexamethasone in Clinical Outcomes After Total Knee Arthroplasty in a Hispanic Population [Phase 4]
Phase 4 clinical trial updating perioperative intravenous dexamethasone effects on outcomes after total knee arthroplasty in a Hispanic popu…
-
CLINICAL_TRIALS trial_result · 2023-09-15Clinical Trial Update: Anterior Advantage With KINCISE [NA]
A clinical trial update for the KINCISE program was terminated; results have been posted previously.
-
FDA approval · 2023-09-07FDA Approved: INDOMETHACIN — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for Indomethacin submitted by Amneal Pharmaceuticals LLC.
-
CLINICAL_TRIALS trial_result · 2023-09-06Clinical Trial Update: Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Osteoarthritis [Phase 2]
A Phase 2 study of LY3526318 in knee osteoarthritis within the Chronic Pain Master Protocol has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2023-09-06Clinical Trial Update: Perioperative Intervention to Improve Post-TKR Support and Function [Phase 2]
Phase 2 clinical trial update on perioperative intervention to improve postoperative support and function after knee replacement.
-
CLINICAL_TRIALS trial_result · 2023-09-06Clinical Trial Update: Enhancing Well-Being Through Exercise During Old Age [NA]
A completed clinical trial investigating how exercise affects well-being in older adults with depression and osteoarthritis; results posted …
-
FDA approval · 2023-08-31FDA Approved: TOLMETIN SODIUM — Supplemental Application (Atland Pharmaceuticals, LLC)
The FDA approved a supplemental application for tolmetin sodium from Atland Pharmaceuticals, LLC. This action approves changes under an appr…